Company
REGN · CIK 0000872589
Sale of 1,131 shares at $857.39 per share.
Reporting Person McCourt Marion · Officer Title EVP Commercial · Transaction Code S
Traded Sep 3, 2026 · Disclosed Sep 3, 2026
Source: SEC Form 4 · 0001663758-26-000002 · filed 2026-09-03 · View filing →
Sale of 1,215 shares at $850.0 per share.
Reporting Person McCourt Marion · Officer Title EVP Commercial · Transaction Code S
Traded Sep 2, 2026 · Disclosed Sep 3, 2026
Source: SEC Form 4 · 0001663758-26-000002 · filed 2026-09-03 · View filing →
Acquisition (code M) of 400 shares at $719.37 per share.
Reporting Person Guarini Kathryn · Transaction Code M
Traded Sep 2, 2026 · Disclosed Sep 3, 2026
Source: SEC Form 4 · 0001992352-26-000007 · filed 2026-09-03 · View filing →
Sale of 400 shares at $850.0 per share.
Reporting Person Guarini Kathryn · Transaction Code S
Traded Sep 2, 2026 · Disclosed Sep 3, 2026
Source: SEC Form 4 · 0001992352-26-000007 · filed 2026-09-03 · View filing →
Acquisition (code M) of 12,282 shares at $381.92 per share.
Reporting Person LAROSA JOSEPH J · Officer Title EVP General Counsel and Secret · Transaction Code M
Traded Aug 19, 2026 · Disclosed Aug 21, 2026
Source: SEC Form 4 · 0001238303-26-000002 · filed 2026-08-21 · View filing →
Disposition (code F) of 9,019 shares at $830.15 per share.
Reporting Person LAROSA JOSEPH J · Officer Title EVP General Counsel and Secret · Transaction Code F
Traded Aug 19, 2026 · Disclosed Aug 21, 2026
Source: SEC Form 4 · 0001238303-26-000002 · filed 2026-08-21 · View filing →
Acquisition (code M) of 6,283 shares at $381.92 per share.
Reporting Person Fenimore Christopher R. · Officer Title EVP Finance CFO · Transaction Code M
Traded Aug 18, 2026 · Disclosed Aug 20, 2026
Source: SEC Form 4 · 0001697422-26-000002 · filed 2026-08-20 · View filing →
Disposition (code F) of 4,599 shares at $813.47 per share.
Reporting Person Fenimore Christopher R. · Officer Title EVP Finance CFO · Transaction Code F
Traded Aug 18, 2026 · Disclosed Aug 20, 2026
Source: SEC Form 4 · 0001697422-26-000002 · filed 2026-08-20 · View filing →
Acquisition (code M) of 800 shares at $376.69 per share.
Reporting Person Zoghbi Huda Y · Transaction Code M
Traded Aug 10, 2026 · Disclosed Aug 12, 2026
Source: SEC Form 4 · 0001681643-26-000006 · filed 2026-08-12 · View filing →
Sale of 800 shares at $800.0 per share.
Reporting Person Zoghbi Huda Y · Transaction Code S
Traded Aug 10, 2026 · Disclosed Aug 12, 2026
Source: SEC Form 4 · 0001681643-26-000006 · filed 2026-08-12 · View filing →
Acquisition (code M) of 400 shares at $719.37 per share.
Reporting Person Guarini Kathryn · Transaction Code M
Traded Aug 10, 2026 · Disclosed Aug 12, 2026
Source: SEC Form 4 · 0001992352-26-000005 · filed 2026-08-12 · View filing →
Sale of 400 shares at $800.0 per share.
Reporting Person Guarini Kathryn · Transaction Code S
Traded Aug 10, 2026 · Disclosed Aug 12, 2026
Source: SEC Form 4 · 0001992352-26-000005 · filed 2026-08-12 · View filing →
Purchase.
Filer Ro Khanna · Chamber House · District CA17 · Transaction Type Purchase · Asset Type Stock
Traded Jul 7, 2026 · Disclosed Aug 7, 2026FILED +31 DAYS
Source: House Clerk PTR · 9116267 · filed 2026-08-07 · View filing →
Purchase.
Filer Alan Armstrong · Chamber Senate · Owner Joint · Transaction Type Purchase · Asset Type Stock
Traded Mar 27, 2026 · Disclosed Jul 21, 2026FILED +116 DAYS
Source: Senate eFD PTR · fda235b3-bad7-4637-8fa1-053f354d929c · filed 2026-07-21 · View filing →
Purchase.
Filer Alan Armstrong · Chamber Senate · Owner Joint · Transaction Type Purchase · Asset Type Stock
Traded Mar 27, 2026 · Disclosed Jul 21, 2026FILED +116 DAYS
Source: Senate eFD PTR · fda235b3-bad7-4637-8fa1-053f354d929c · filed 2026-07-21 · View filing →
Sale.
Filer Gilbert Cisneros · Chamber House · District CA31 · Transaction Type Sale · Asset Type Stock
Traded May 15, 2026 · Disclosed Jun 8, 2026FILED +24 DAYS
Source: House Clerk PTR · 20034713 · filed 2026-06-08 · View filing →
REGENERON PHARMACEUTICALS, INC.